The first embodiment of the present invention provides a process, which
includes:
in a continuous process in a membrane reactor, asymmetrically hydrogenating
at least one C.dbd.C, C.dbd.N or C.dbd.O double bond with a catalyst.
Another embodiment of the present invention provides a ligand, which
includes at least one di-1,3-aminophosphine homochiral active center;
optionally, a linker; and a molecular weight-enlarging polymer; wherein
the active center is bound to the molecular weight-enlarging polymer
through the linker or is bound directly to the molecular weight-enlarging
polymer; and wherein the linker is defined in the claims. Another
embodiment of the present invention provides a process for preparing the
above-noted ligand, and a catalyst that includes the above-noted ligand.